Bausch Health Companies (TSE:BHC) Stock Price Up 3% – Still a Buy?

Bausch Health Companies Inc. (TSE:BHC) shares rose 3% during mid-day trading on Thursday . The company traded as high as C$11.67 and last traded at C$11.61. Approximately 76,142 shares changed hands during mid-day trading, a decline of 44% from the average daily volume of 137,096 shares. The stock had previously closed at C$11.27.

Analysts Set New Price Targets

Separately, Evercore ISI raised shares of Bausch Health Companies to a “hold” rating in a report on Tuesday, October 15th.

Bausch Health Companies Stock Up 3.0 %

The firm has a 50 day moving average of C$11.63 and a two-hundred day moving average of C$10.18. The stock has a market capitalization of C$4.26 billion, a PE ratio of -6.63, a P/E/G ratio of 0.21 and a beta of 0.77. The company has a current ratio of 1.19, a quick ratio of 0.58 and a debt-to-equity ratio of 7,583.76.

Bausch Health Companies (TSE:BHC) last announced its quarterly earnings results on Wednesday, October 30th. The company reported C$1.53 earnings per share for the quarter, beating analysts’ consensus estimates of C$1.43 by C$0.10. The business had revenue of C$3.42 billion during the quarter, compared to analysts’ expectations of C$3.36 billion. Bausch Health Companies had a negative return on equity of 2,304.54% and a negative net margin of 5.12%. Equities research analysts anticipate that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.